Treatment of Helicobacter pylori

doi:10.3748/wjg.v7.i3.303

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2418)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

182

HTML

1919

Figures (1-1)

190

Tables (1-4)

127

Sum=2418

Jun 15, 2001 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 15, 2001; 7(3): 303-307
Published online Jun 15, 2001. doi: 10.3748/wjg.v7.i3.303

Table 2 Low dose triple therapy

Therapy	PPI or RBC	PPI or RBC
	Amoxycillin	Clarithromycin
	Clarithromycin	Metronidazole
Dosing	b.d.	b.d.
	1 g b.d.	250 mg b.d.
	500 mg b.d.	400 mg b.d.
Duration		One week
Side effects	Nausea, diarrhoea, taste disturbances
H. pylori eradication	90%	90% in MSS
H. pylori eradication		75% in MRS

PPI: Proton pump inhibitor; RBC: Ranitidine bismuth citrate; b.d.: Twice daily; MSS: Metronidazole-sensitive strain of H. pylori; MRS: Metronidazole-resistant strain of H. pylori

Citation: Harris A. Treatment of Helicobacter pylori. World J Gastroenterol 2001; 7(3): 303-307
URL: https://www.wjgnet.com/1007-9327/full/v7/i3/303.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i3.303